Isolation and polyphasic characterization of biofilm-inhibiting actinomycete and evaluation of its crude extract for antimicrobial, antioxidant and cytocompatibility activities against RAW 264.7 macropahges.
The Microbe · 2026-11 · 100835
DOI: 10.1016/j.microb.2026.100835 ↗Kurz gefasst
Fachartikel in der Zeitschrift The Microbe, 2026-11. Verfasst von Shweta Mallikarjun und 1 weiteren Autor:innen. Die Arbeit nennt 73 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Abstract (Originalsprache)
The present investigation aimed to isolate actinomycetes from soil samples of the Kalaburagi region, characterize the biofilm inhibiting crude extract obtained from a potent actinomycete isolate, and evaluate its biomedical properties. A total 48 actinomycete isolates were isolated from soil samples and screened for antagonistic activity against 12 Candida strains. Out of 48 isolates, 16 isolates showed antagonistic property and were further subjected to secondary screening by agar well diffusion method. Among potent strain VSG-9 ethyl acetate crude extract exhibited maximum of 16±0.33 mm zone of inhibition against Candida haemulonii MTCC8303 and minimum of 6±0.5 mm ZOI against C.glabrata MTCC3981 as compared to 22±0.33 and 11±0.83 mm in fluconazole. For the bacterial strains, crude extract showed maximum of 15±0.66 mm ZOI against S.typhi and minimum of 8±0.83 mm against S.epidermidis as compared to 18±0.66 and 12±0.66 mm in Streptomycin, respectively. The MIC value of the crude extract was determined at 40 μg/ml against Candida albicans 3017, Candida tropicalis 1406, and Salmonella typhi. The crude extract at 500 µg/ml concentration inhibited biofilm formation in Candida albicans, Escherichia coli, and Enterococcus faecalis . The crude extract also exhibited notable antioxidant and anti-inflammatory activities. The extract exhibited no significant cytotoxicity against LPS-induced RAW 264.7 cells up to 50 μg/ml, while a significant reduction in cell viability was observed at 100 μg/ml. At 50 μg/ml, the extract reduced COX-2 levels by 42.88%, indicating a potential antiinflammatory effect under the tested conditions. Based on the morphological, biochemical, chemotaxonomical characteristics and 16S rRNA sequencing, VSG-9 was identified as Streptomyces pseudogriseolus.
Zitieren
APA
Mallikarjun, S., & M, V. G. (2026). Isolation and polyphasic characterization of biofilm-inhibiting actinomycete and evaluation of its crude extract for antimicrobial, antioxidant and cytocompatibility activities against RAW 264.7 macropahges. The Microbe, 100835. https://doi.org/10.1016/j.microb.2026.100835
Vancouver
Mallikarjun S, M VG. Isolation and polyphasic characterization of biofilm-inhibiting actinomycete and evaluation of its crude extract for antimicrobial, antioxidant and cytocompatibility activities against RAW 264.7 macropahges. The Microbe. 2026:100835. doi:10.1016/j.microb.2026.100835
BibTeX
@article{Mallikarjun2026,
author = {Mallikarjun, Shweta and M, Vidyasagar Gunagambhire},
title = {Isolation and polyphasic characterization of biofilm-inhibiting actinomycete and evaluation of its crude extract for antimicrobial, antioxidant and cytocompatibility activities against RAW 264.7 macropahges},
journal = {The Microbe},
year = {2026},
pages = {100835},
doi = {10.1016/j.microb.2026.100835}
}
EUVIMED